By: Justin Jackson
A single 40-mg dose of the antiviral drug suraxavir marboxil significantly shortened flu symptom resolution time in male patients aged 5–65, according to research led by the China-Japan Friendship Hospital in China. Intriguingly, suraxavir did not effectively shorten symptom resolution time for female participants in the study.